Janus Henderson Group’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.U
E
Janus Henderson Group's IBER.U Position: Q3 2022 in Review
Janus Henderson Group sold out of Ibere Pharmaceuticals Units (IBER.U) in Q3 2022, closing a stake of 52,917 shares — an estimated $524K sold.
Janus Henderson Group first reported a position in IBER.U in Q1 2021 and held it in 6 quarters. The position peaked at $524K in Q2 2022. 13 funds tracked by Wall St. Rank hold IBER.U as of Q3 2022.
- Janus Henderson Group reported no remaining Ibere Pharmaceuticals Units position as of Q3 2022 after selling out during the quarter.
- Janus Henderson Group sold 52,917 Ibere Pharmaceuticals Units shares in Q3 2022, an estimated $524K.
- Janus Henderson Group first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 6 quarters.
- Janus Henderson Group's Ibere Pharmaceuticals Units position peaked at $524K in Q2 2022.
- 13 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q3 2022.
Based on Janus Henderson Group's 13F filing for Q3 2022, filed 14 Nov 2022.